| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Jealousy and Territoriality in the Workplace |
|
Digg It - Jealousy and Territoriality in the Workplace
There are times in every company when people "butt heads" with each other whether subtly or overtly. These conflicts, if persistent, can become detrimental to the busin According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ess and should be addressed if possible. If you are a manager or co-worker of the conflicting parties, you can have a positive effect on tension reduction. If you are ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in an underling of one or both parties, hide under the desk and avoid the crossfire unless you have an exceptionally strong relationship with a "superior". If you are in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. a position to help, there are two things to do: gain understanding, then take action. The understanding part is interesting, especially if you watch National Geographi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe c specials on tv, or on your phone if you are exceptionally wired. Doesn't it seem that the non-alpha males are always butting each other so they can get chummier with d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro he alpha and mate with better gals? Those head-butts can look quite ferocious, and indeed they should. The young bucks are fighting for nothing less than the optimized ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc survival of their line. It is not a laughing matter for them. They may not die if they lose the conflict, but their progeny will suffer in number and quality. And of easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi course it goes without saying that the more determined, capable and intelligent of those bucks will win the conflict and over generations, alphas and wannabees will be nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically naturally bred with those traits in spades. To enormously simplify a point, your workplace sparring partners may be enacting the essential primal drama of survival. Mo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ rphed, twisted and filtered through millennia of the human experience, but underneath it all, a head-butt in the prairie. Here is what there is to understand: 1. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi he feelings run deep and strong and for good reason. We're talking nature here. 2. If it is an unequal match and nature takes its course, the little guy will get c ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a lobbered and should slink back to his cubicle, licking whatever body part he can reach. 3. If it a pretty equal match, the contestants will need either an open ven dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ue for the final battle where a clear winner will be established, or they will need to be separated. Here is what there is to do: 1. As a manager, understand that cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin a certain amount of competition is good for the herd, uh, company. But beyond that the company can suffer. If the manager perceives that there are more negatives than tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen positives to the competition, he (or she) should remember the alpha role and head-butt the boata dem (Chicago-ese for "both of them") until they remember who is the big t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel boss. Example: "Guys, your behavior is making it hard for others to do their work and is creating a bad atmosphere around here. Shake hands and get on the same team, o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r take your problem to another company." 2. As a co-worker, understand that ultimately the herd survives if it cooperates and stays together. As much as competition ma y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products y advance the individual, true cooperation advances the whole company. Then you can be vocal about these ideas which will encourage the rest of the tribe, I mean the bu . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de siness, to also express them. Eventually it will seep into the thickened sculls of the contestants. Example: "I am getting very tired of our work being interrupted by elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the feud between those two. It is taking our minds off of what we really need to be doing. If they keep it up, we are all going down the tubes. We should pull together. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Making the Difference with Product Ideas Secrets to Effective Staff Meetings
|